Abemaciclib can improve chances of certain type of cancer not returning after surgery by more than 30%
Thousands of women in England with breast cancer are to benefit from a new pill on the NHS which reduces the risk of the disease coming back.
The National Institute for Health and Care Excellence (Nice) has given the green light to abemaciclib, which cuts the chance of breast cancer returning after a patient has had surgery to remove a tumour.
Continue reading…
